Table 2 Etiological distribution of SBIs in patients hospitalized with COVID-19
Bacteria | N (%) in different sites | |||
|---|---|---|---|---|
Lungs | bloodstream | Urinary tract | Total | |
Gram-negative | 105 (95.5) | 27 (62.8) | 4 (50.0) | 136 (85.5) |
A. baumannii | 47 (42.7) | 9 (20.9) | 1 (12.5) | 57 (35.8) |
K. pneumoniae | 34 (30.9) | 15 (34.9) | 0 (0) | 49 (30.8) |
S. maltophilia | 10 (9.1) | 0 (0) | 0 (0) | 10 (6.3) |
Pseudomonas aeruginosa | 7 (6.4) | 0 (0) | 0 (0) | 7 (4.4) |
Escherichia coli | 4 (3.6) | 1 (2.3) | 3 (37.5) | 8 (5.0) |
others | 3 (2.7) | 2 (4.7) | 0 (0) | 5 (3.1) |
Gram-positive | 5 (4.5) | 16 (37.2) | 2 (25.0) | 23 (14.5) |
Staphylococcus aureus | 2 (1.8) | 1 (2.3) | 0 (0) | 3 (1.9) |
Staphylococcus epidermidis | 0 (0) | 2 (4.7) | 0 (0) | 2 (1.3) |
Staphylococcus hominis | 0 (0) | 5 (11.6) | 0 (0) | 5 (3.1) |
Staphylococcus haemolyticus | 0 (0) | 2 (4.7) | 0 (0) | 2 (1.3) |
Enterococcus faecium | 0 (0) | 4 (9.3) | 2 (25.0) | 6 (3.8) |
others | 3 (2.7) | 2 (4.7) | 0 (0) | 5 (3.1) |
Total N (%) | 110 (100) | 43 (100) | 6 (100) | 159 (100) |